TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05819697

Intervention type: OTHER
Intervention: FIRE Trial/Track Your Happiness notifications
Description: All participants will receive notifications to their smart phones 3 times a day for 12 weeks. They will be asked questions related to burning mouth, to exercise as well as non-clinical Track Your Happiness questions, e.g., Are you interacting with anyone right now? How do you feel right now?
Study: NCT05984043

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Biofeedback
Description: Heart-rate Variability Biofeedback

Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist
Description: Waitlist control group
Study: NCT05820854

Intervention type: OTHER
Intervention: Self-assess and reporting self-care self-efficacy levels
Description: Patients will have to self-report the self-care self-efficacy levels they experienced in managing the OAC therapy.
Study: NCT03826238

Intervention type: DIAGNOSTIC_TEST
Intervention: Validation Gate task
Description: The task is to observe several moving unfilled white circles on a dark background. The circles move in straight paths. Every so often, a randomly selected circle will displace to a point inconsistent with its trajectory, which will look like a jump. The subjects' task is to press the space bar every time they detect a displacement (e.g. jump). A session consists of 30 minutes, it starts with 2 training blocks which are followed by 2 no-cognitive load blocks and 6 blocks with increasing cognitive load conditions. During the assessment the eye movement as well as the key presses are registered in order to calculate early and late saccades as well as conscious reporting. Resting-state EEG will also be recorded and compared to the ones of age-matched healthy controls. Task-dependent EEG data will be recorded during the Validation Gate task.

Intervention type: DIAGNOSTIC_TEST
Intervention: Validation Gate task
Description: The task is to observe several moving unfilled white circles on a dark background. The circles move in straight paths. Every so often, a randomly selected circle will displace to a point inconsistent with its trajectory, which will look like a jump. The subjects' task is to press the space bar every time they detect a displacement (e.g. jump). A session consists of 30 minutes, it starts with 2 training blocks which are followed by 2 no-cognitive load blocks and 6 blocks with increasing cognitive load conditions. During the assessment the eye movement as well as the key presses are registered in order to calculate early and late saccades as well as conscious reporting. Resting-state EEG will also be recorded and compared to the ones of age-matched healthy controls. Task-dependent EEG data will be recorded during the Validation Gate task.

Intervention type: DIAGNOSTIC_TEST
Intervention: Validation Gate task
Description: The task is to observe several moving unfilled white circles on a dark background. The circles move in straight paths. Every so often, a randomly selected circle will displace to a point inconsistent with its trajectory, which will look like a jump. The subjects' task is to press the space bar every time they detect a displacement (e.g. jump). A session consists of 30 minutes, it starts with 2 training blocks which are followed by 2 no-cognitive load blocks and 6 blocks with increasing cognitive load conditions. During the assessment the eye movement as well as the key presses are registered in order to calculate early and late saccades as well as conscious reporting. Resting-state EEG will also be recorded and compared to the ones of age-matched healthy controls. Task-dependent EEG data will be recorded during the Validation Gate task.
Study: NCT04811846

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar transurethral resection of bladder tumor (TURBT)
Description: Standard resection in piecemeal technique with standard bipolar cutting loop. (Storz medical, 27040 GP1)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
Description: Vaporization of bladder tumor with standard bipolar vaporization electrode. (Storz medical, 27040 NB)
Study: NCT06121089

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ileocecal resection with extended D3 lymphadenectomy.
Description: Laparoscopy ileocecal resectionith extended D3 lymphadenectomy including 201, 202, 203 and 213 groups of lymph nodes. Manual double-row ileo-ascendo-anastomosis.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Right hemicolectomy with D3 lymphadenectomy.
Description: Laparoscopy right hemicolectomy with D3 lymphadenectomy including 201, 202, 203, 213, 211, 212, 221, 222-rt groups of lymph nodes. Manual double-row ileo-transverse-anastomosis.
Study: NCT06276426

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soy foods
Description: Soy milk, soy yogurt, tofu, tempeh, soy nuts, edamame, soy protein bar, and soy-based frozen meat substitutes.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Soy Plant-Based Foods
Description: Pea milk, almond milk yogurt, chickpeas, chickpea chips, lentil chips, non-soy protein bar, and non-soy based frozen meat substitutes.
Study: NCT06119789

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib
Description: imatinib treatment based on molecular alterations
Study: NCT06176768

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3972406
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3972406
Description: Administered orally
Study: NCT04709575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5713
Description: Administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5714
Description: Administered subcutaneously
Study: NCT06176768

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally
Study: NCT06308198

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-151586
Description: Intramuscular Injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-151586
Description: Intramuscular Injections

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular Injections
Study: NCT06154707

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab Injection
Description: Denosumab injection 60mg (1.0ml/ branch, Jiangsu Taikang Biological Medicine Co., LTD., s20233111), once every 6 months, 60mg, subcutaneous injection, at the same time to supplement calcium and vitamin D.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline injection (1.0ml/ branch)
Description: Placebo drug, the main component of normal saline injection (1.0ml/ dose). In addition to the different production batch number, its appearance, character, specification, administration mode and frequency are exactly the same as the experimental group of drugs (different production batch number is convenient for later unblinding reference). Take calcium and vitamin D supplements.
Study: NCT05079828

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 18F-PSMA-1007
Description: PET/CT scan using 18F-PSMA-1007

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 18F-PSMA-1007
Description: PET/CT scan using 18F-PSMA-1007

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 68Ga-PSMA-11
Description: PET/CT scan using 68Ga-PSMA-11

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 68Ga-PSMA-11
Description: PET/CT scan using 68Ga-PSMA-11
Study: NCT05939362

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI follow-up
Description: MRI follow-up for patient with early onset Alzheimer's disease
Study: NCT05287828

Intervention type: OTHER
Intervention: Surgeons CT scan analysis
Description: Surgeons extract indicators using standard methods of analysis

Intervention type: OTHER
Intervention: Surgeons CT scan analysis
Description: Surgeons extract indicators using standard methods of analysis

Intervention type: OTHER
Intervention: Surgeons CT scan analysis
Description: Surgeons extract indicators using standard methods of analysis

Intervention type: OTHER
Intervention: Surgeons CT scan analysis
Description: Surgeons extract indicators using standard methods of analysis

Intervention type: DEVICE
Intervention: PRAEVAorta CT scan analysis
Description: CT scans are analysed using PRAEVAorta Suite which is composed of the software PRAEVAorta 2 and PRAEVAorta Web. Indicators extraction is fully automatic.

Intervention type: DEVICE
Intervention: PRAEVAorta CT scan analysis
Description: CT scans are analysed using PRAEVAorta Suite which is composed of the software PRAEVAorta 2 and PRAEVAorta Web. Indicators extraction is fully automatic.
Study: NCT04709575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5715
Description: Administered subcutaneously

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo that replaces REGN5713-5714-5715
Study: NCT05283252

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3-D printed Guide
Description: Guided Endodontic micro-surgery

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional Endodontic Micro-Surgery
Description: Free-hand endodontic micro-surgery
Study: NCT06476223

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artificial saliva containing cumin and ginger extract
Description: The sample will be sprayed 2 puff/time, 3 times/day, for 14 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The sample will be sprayed 2 puff/time, 3 times/day, for 14 days.
Study: NCT05653960

Intervention type: OTHER
Intervention: EMR or ESD
Description: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two main endoscopic treatment options for colorectal neoplasms
Study: NCT06193746

Intervention type: DEVICE
Intervention: non-invasive laser therapy
Description: (diode laser, continuous output, in skin contact mode, 0.005W,0.2cm,beam spot area 0.03cm2, 288j/cm ,1800s) in the morning session, we measured lipid profile and kidney function before and after treatment to measure improvement
Study: NCT04985630

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mitopure
Description: Fruit flavored sachet containing fixed dose of Mitopure™ (Proprietary Urolithin A)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pomegranate Juice
Description: 100% Pomegranate juice
Study: NCT05517122

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM)
Description: 500 mg a day

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside (NR)
Description: 1000 mg a day

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Mono Nucleotide (NMN)
Description: 1000 mg a day

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline cellulose
Description: 500 mg a day
Study: NCT04828668

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C)
Description: Hemp seed oil

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C)
Description: Hemp seed oil
Study: NCT05287828

Intervention type: DEVICE
Intervention: PRAEVAorta CT scan analysis
Description: CT scans are analysed using PRAEVAorta Suite which is composed of the software PRAEVAorta 2 and PRAEVAorta Web. Indicators extraction is fully automatic.

Intervention type: DEVICE
Intervention: PRAEVAorta CT scan analysis
Description: CT scans are analysed using PRAEVAorta Suite which is composed of the software PRAEVAorta 2 and PRAEVAorta Web. Indicators extraction is fully automatic.
Study: NCT06211751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3909 tablets
Description: TQB3909 is a protein inhibitor.
Study: NCT06650085

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Loop ileostomy
Description: Patient undergoing anterior rectal resection will receive loop ileostomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Loop colostomy
Description: Patient undergoing anterior rectal resection will receive loop colostomy
Study: NCT06649786

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic superior rectal mucosal ligation
Description: The patient takes the left side decubitus position, the endoscope is connected with 6 serial ligators, the cup of the sleeve is pointed at the upper edge of the straight anal line and the rectal mucosa is continuously aspirated under negative pressure. The mucosa enters the sleeve and sees a full-screen red sign. The sensing loop is successfully triggered, indicating that the loop is complete.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic hemorrhoid ligation
Description: The patient takes the left side decubitus position,the endoscope is connected with 6 serial ligators,the cup the sleeve is aligned with the base of the hemorrhoid (above the dentate line) for continuous negative pressure suction.The hemorrhoid enters the sleeve and sees a full-screen red sign. Turn the handle of the sleeve clockwise and feel that the loop is successfully triggered, the ligature is completed.
Study: NCT06650358

Intervention type: DEVICE
Intervention: Light Adjustable Lens+
Description: The Light Adjustable Lens+ (LAL+) is a posterior chamber, UV absorbing, three-piece, foldable, photo reactive silicone intraocular lens with a squared-posterior optic edge intended to be implanted in the capsular bag following phacoemulsification. Selective exposure to the implanted LAL+ using the Light Delivery Device (LDD) to deliver a spatially profiled UV light produces modifications in the lens curvature resulting in a spherical or spherocylindrical power change postoperatively. A subsequent lock-in exposure is delivered to the implanted LAL+ to stabilize the lens power. The LAL+ has a modified aspheric anterior surface that creates a small continuous increase in central lens power, which is designed to slightly extend the depth of focus.
Study: NCT05897931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Connective tissue massage
Description: Connective Tissue Massage will be applied by starting from the lumbosacral region, continuing from the lower thoracic region, and finishing by applying it to the scapular region, interscapular region, and cervico-occipital region.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Tape Application
Description: Taping will be applied to the levator scapula and upper trapezius muscles in a Y shape, with 25% tension and while the participants were in an upright position. Again in the same position, this time the C shaped taping technique will be adhered with 50% tension from the middle fibers of the trapezium to the last rib.
Study: NCT06058572

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin with allogeneic stem cell transplant
Description: Tab Rifaximin 200 mg will begiven orally twice daily from day -8 to day +60 of allogeneic stem cell transplant in acute leukemia patients. This will be in addition to standard of care posttransplant treatment

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Allogeneic stem cell transplant
Description: Standard of care treatment including standard anti GVHD measures, antibiotic support and transfusions as needed.
Study: NCT04430387

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: The saliva ejector
Description: A thin suction tube that draws water, saliva, blood, and debris from the mouth to provide patient comfort, preventing patient from constantly having to sit up and spit while maintain a clear operative field. It is connected through the low-volume suction hose in the dental chair. It can be held by the dental assistant, the dental provider or by the patient. In practice, it can be also contoured and hang by the cheek of the patient due to its light weight.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: The high-volume evacuator
Description: The high-velocity air evacuation device. It is connected through the high-volume suction hose in the dental chair. It is operated by a dental assistant during the dental treatment, owing to the challenge posed by the rigid disposable attachment and bulky high-volume suction hose.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: The DryShield
Description: The device is attached to the high-volume suction hose to provide continuous suction of intraoral fluid and debris, and also simultaneous isolation to both maxillary and mandibular quadrants on the same side. Other advantages of these devices include retracting the tongue and cheek, and prevention of aspiration.
Study: NCT05316662

Intervention type: DRUG
Intervention: Semaglutide
Description: Participants will be treated with commercially available oral semaglutide according to local label and to routine clinical practice at the discretion of the treating physician. The decision to initiate treatment with commercially available oral semaglutide has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician based on local label before and independently from the decision to include the participant in this study.
Study: NCT06484153

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: Two doses of pirfenidone (200 mg,tid,po;500 mg,tid,po) were set up. Using the 3+3 design, the DLT observation period is 28 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: 3mg, orally, qd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200mg iv every 3 weeks
Study: NCT04655716

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate 150Meq/L/D5W Inj
Description: Urine alkalinisation will be performed to achieve urine pH 7.5-8.5. Urine alkalinisation will be continued for up to 10 days or until patient is discharged or until primary endpoint is reached. Urine pH will be measured at point of care by dipstick.
Study: NCT05287828

Intervention type: DEVICE
Intervention: PRAEVAorta CT scan analysis
Description: CT scans are analysed using PRAEVAorta Suite which is composed of the software PRAEVAorta 2 and PRAEVAorta Web. Indicators extraction is fully automatic.
Study: NCT04823442

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mirabegron
Description: Mirabegron: a single dose of 200 mg mirabegron (4 tablets of 50 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirabegron
Description: Mirabegron: a single dose of 200 mg mirabegron (4 tablets of 50 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisoprolol Fumarate
Description: a single dose of 10 mg (2 tablets of 5 mg)
Study: NCT05125406

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure therapy with Virtual Reality.
Description: Experimental arm patients will be offered Exposure therapy with Virtual Reality (ETRV) support with a virtual reality headset. A scenario with progressively increasing stress levels linked to the ICU environment and different situational contexts (alarms, etc.) will be presented to patients. This habituation to the potentially anxiety context of ICU will reduce the occurrence of psycho-cognitive disorders by progressive extinction phenomenon.
Study: NCT06410014

Intervention type: OTHER
Intervention: No intervention is performed
Description: The study is observational
Study: NCT05801666

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture 5 points

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Acupuncture
Description: Acupuncture 5 points
Study: NCT06016296

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Movement and Storytelling Intervention
Description: The 40-minute sessions will include three moments: (i) warm-up (5 minutes), which consists of joint mobility exercises and introduction to the motor story of the week; (ii) main part (25 minutes), which incorporates the narration of the motor story by the educator initially, as well as the participation of the children, through their own corporeality with movements based mainly on FMS (locomotion skills and object control) and two way verbal interaction based on questions allusive to the narration delivered by the educator or direct verbal participation cast by each child and; (iii) cool down (10 minutes), where space is provided for the children to gradually return to calm, together with feedback on the contents addressed during the session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Movement and Storytelling Intervention
Description: The 40-minute sessions will include three moments: (i) warm-up (5 minutes), which consists of joint mobility exercises and introduction to the motor story of the week; (ii) main part (25 minutes), which incorporates the narration of the motor story by the educator initially, as well as the participation of the children, through their own corporeality with movements based mainly on FMS (locomotion skills and object control) and two way verbal interaction based on questions allusive to the narration delivered by the educator or direct verbal participation cast by each child and; (iii) cool down (10 minutes), where space is provided for the children to gradually return to calm, together with feedback on the contents addressed during the session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Movement and Storytelling Intervention
Description: The 40-minute sessions will include three moments: (i) warm-up (5 minutes), which consists of joint mobility exercises and introduction to the motor story of the week; (ii) main part (25 minutes), which incorporates the narration of the motor story by the educator initially, as well as the participation of the children, through their own corporeality with movements based mainly on FMS (locomotion skills and object control) and two way verbal interaction based on questions allusive to the narration delivered by the educator or direct verbal participation cast by each child and; (iii) cool down (10 minutes), where space is provided for the children to gradually return to calm, together with feedback on the contents addressed during the session.
Study: NCT05703009

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacrosidase Oral Solution
Description: Study drug

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06211751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3702 tablets
Description: TQB3702 is a kinase inhibitor.
Study: NCT05317663

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Test Health Warning Label (HWL)
Description: Effect of Health Warning Label (HWL)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Test without Health Warning Label (no-HWL)
Description: Effect of no Health Warning Label (no-HWL)